Related Experiment Videos
[Etiopathogenesis of giant cell arteritis]
1Servicio de Medicina Interna. Hospital Virgen del Camino. Spain. manuel.casas@unavarra.es
Insights
Giant cell arteritis (GCA) is a large vessel vasculitis affecting arteries like the aorta. Its pathogenesis involves immune cells and leads to arterial stenosis, ischemia, and potential aneurysms.
Area of Science:
- Immunology
- Rheumatology
- Vascular Biology
Background:
- Giant cell arteritis (GCA) is a large and medium-sized artery vasculitis, primarily affecting the aorta and its extracranial branches.
- Characterized by inflammatory infiltrates near the internal elastic lamina, including lymphocytes, macrophages, and often multinucleate giant cells.
- Disease morbidity stems from luminal stenosis causing distal ischemia and arterial wall weakening leading to aneurysms.
Purpose of the Study:
- To elucidate the immune mechanisms underlying the pathogenesis of giant cell arteritis.
- To understand the role of T cells, macrophages, and cytokines in arterial inflammation and damage.
- To explore the relationship between GCA and polymyalgia rheumatica.
Main Methods:
- Review of existing literature on GCA pathogenesis.
- Analysis of immune cell involvement (T cells, macrophages) and cytokine production (gamma-INF).
- Examination of histological features and their correlation with clinical manifestations.
Main Results:
- Pathogenesis is immune-mediated, involving gamma-INF-producing T cells and activated macrophages.
- Macrophage-mediated destruction of arterial elastic tissue and promotion of neoangiogenesis contribute to disease.
- Systemic inflammation with acute phase reactants and non-specific symptoms are characteristic.
- A significant association exists between GCA and polymyalgia rheumatica.
Conclusions:
- The pathogenesis of GCA involves a complex interplay of immune cells and inflammatory mediators, leading to arterial damage.
- Understanding these immune mechanisms is crucial for developing targeted therapies.
- The link with polymyalgia rheumatica warrants further investigation.
Abstract:
Giant cell arteritis is a vasculitis of large and medium size arteries, especially those of the aortic arch with an extracranial distribution, but also the aorta and some of its larger branches. It is characterised by the presence of mononuclear inflammatory infiltrates close to the internal elastic lamina formed by lymphocytes and macrophages, which in slightly more than 50% of the cases contain multinucleate giant cells. The morbidity associated with this disease is related to phenomena of distal ischemia to the luminal stenosis of the inflamed arteries, and to a lesser extent to the formation of aneurisms due to the weakening of the arterial wall. With an unknown aetiology, its pathogenesis is immune through the migration and location of gamma-INF -producing T cells in the adventitia of the inflamed arteries, it being assumed that this is the place of immune stimulation by a still unidentified antigen. The recruitment and activation of macrophages by this cytokine is one of the most important points of its pathogenesis. The destruction by these of the arterial elastic tissue is a relevant phenomenon, as is the production of other factors promoting neoangiogenesis and a proliferation of neointime, responsible through obliterating light for the ischemic manifestations of the disease. The process is accompanied by an important systemic repercussion characterised by a strong reaction of acute phase and general but barely specific symptoms of disease. On the other hand, an important percentage of patients show a clinical picture of polymyalgia rheumatica, an entity that has a historical and controversial relationship to this arteritis. In recent years important contributions have been made to the understanding of the immune mechanisms involved in its pathogenesis.